William Steinberg, MD in Meadowbrook, PA - General Practice

William Steinberg, MD is a General Practice physician based in Meadowbrook, Pennsylvania. William Steinberg is licensed to practice in Pennsylvania (license number MD020929E) and his current practice location is 1221 Wrack Rd, Meadowbrook, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (215) 572-8101.

NPI number for William Steinberg is 1831438324 and his current mailing address is 1221 Wrack Rd, Meadowbrook, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831438324.

Contact Information

	William Steinberg, MD
	1221 Wrack Rd, Meadowbrook, PA 19046-2553
	(215) 572-8101
	Not Available

Physician's Profile

Full Name	William Steinberg
Gender	Male
Speciality	General Practice
Location	1221 Wrack Rd, Meadowbrook, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1831438324
Provider Enumeration Date: 02/05/2013
Last Update Date: 02/05/2013

Medical Identifiers

Medical identifiers for William Steinberg such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831438324	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	MD020929E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Steinberg is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Steinberg, MD 1221 Wrack Rd, Meadowbrook, PA 19046-2553 Ph: (215) 572-8101	William Steinberg, MD 1221 Wrack Rd, Meadowbrook, PA 19046-2553 Ph: (215) 572-8101

News Archive

FGF protein may play key role in breast and prostate cancer, shows research

Simply put, cancer is caused by mutations to genes within a cell that lead to abnormal cell growth. Finding out what causes that genetic mutation has been the holy grail of medical science for decades.

DATIS, NPS MedicineWise partner to deliver face-to-face educational visits to GPs across South Australia

A new three-year contract launched in Adelaide today will see the Drug and Therapeutics Information Service (DATIS) based at the Repatriation General Hospital continue to deliver NPS MedicineWise educational visiting programs to general practitioners (GPs) across South Australia.

Isis commences ISIS-GCGRRx and ISIS-GCCRRx Phase 1 studies for type 2 diabetes

Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.

Comprehensive review of cell migration

Cell migration is a highly complex process which involves several compartments of the cell, including surface receptors, signalling elements and the cytoskeleton.

William Steinberg, MD - General Practice in Meadowbrook, PA